OR WAIT null SECS
© 2024 MJH Life Sciences and BioPharm International. All rights reserved.
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Both adherent and suspension cell culture approaches have their pros and cons, which must be considered for process development.
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
Re-evaluating the basics of mAb production may be beneficial for the biopharma industry as a whole.
August 02, 2023
Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.
July 27, 2023
MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.
July 02, 2023
The choice of expression system requires wise consideration of product complexities.
June 15, 2023
The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.
June 01, 2023
Media developers and vector manufacturers face a combination of challenges and opportunities.
May 02, 2023
It is crucial to examine the context in which single-use waste is viewed.
April 12, 2023
Lives are saved when time from vein to vein decreases.
April 02, 2023
The innovation of going from stainless-steel bioreactors to fixed-bed bioreactors shows an evolution in upstream optimization.
March 02, 2023
Process and plasmid design optimization, disposable equipment, and flexible platform processes all play important roles.
Decreasing vein to vein time saves lives.